GAS5 and central nervous system cancer: The GAS5-mediated sponging of miRNAs includes targets such as miR-223 in renal cell carcinoma [72]; miR-135b [73] or miR-1323 [74] in hepatocellular carcinoma; miR-106b in cervical cancer [75]; miR-182-5p in colorectal cancer [76]; miR-181c-5p in pancreatic cancer [77]; miR-424 in multiple malignant phenotypes of glioma [78]; miR-145 in prostate cancer [79]; miR-135b in non-small cell lung cancer [80]; and miR-34a in solid tumors [81].